GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
South Korea · Delayed Price · Currency is KRW 13,240
+330 (2.56%)
Jun 12, 2026, 3:30 PM KST
GemVax&KAEL Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 87,415 | 81,531 | 62,692 | 72,209 | 75,804 | 60,371 |
Other Revenue | - | - | -0 | - | - | -0 |
| 87,415 | 81,531 | 62,692 | 72,209 | 75,804 | 60,371 | |
Revenue Growth (YoY) | 44.89% | 30.05% | -13.18% | -4.74% | 25.56% | -8.06% |
Cost of Revenue | 51,648 | 46,715 | 43,209 | 46,270 | 54,082 | 41,704 |
Gross Profit | 35,767 | 34,816 | 19,482 | 25,938 | 21,722 | 18,667 |
Selling, General & Admin | 15,998 | 14,348 | 20,781 | 16,360 | 12,587 | 13,462 |
Research & Development | 11,766 | 14,631 | 35,064 | 15,670 | 11,634 | 7,241 |
Amortization of Goodwill & Intangibles | 286.28 | 303.91 | 328.44 | 300.61 | 179 | 150.41 |
Other Operating Expenses | 676.41 | 640.21 | 354.7 | 375.96 | 291.92 | 308.43 |
Operating Expenses | 29,783 | 31,023 | 57,819 | 33,807 | 25,652 | 21,117 |
Operating Income | 5,984 | 3,793 | -38,337 | -7,868 | -3,929 | -2,450 |
Interest Expense | -6,383 | -6,647 | -3,161 | -462.86 | -445.31 | -404.96 |
Interest & Investment Income | 214.48 | 212.8 | 381.18 | 294.97 | 170.17 | 272.83 |
Earnings From Equity Investments | -5,725 | -6,612 | -2,968 | -10,855 | -7,004 | 11,719 |
Currency Exchange Gain (Loss) | 673.63 | 97.86 | -64.44 | 80.31 | 29.09 | 325.36 |
Other Non Operating Income (Expenses) | -546.84 | -1,165 | -24,132 | -48.49 | 462.77 | 519.5 |
EBT Excluding Unusual Items | -5,782 | -10,320 | -68,281 | -18,860 | -10,717 | 9,981 |
Gain (Loss) on Sale of Investments | 3,678 | 203.5 | -18,022 | -2,531 | -8,538 | 2,166 |
Gain (Loss) on Sale of Assets | 22.11 | 11.55 | 119.06 | -253.09 | -83.14 | -6.64 |
Asset Writedown | -1,423 | -1,322 | -1,619 | -5,704 | -266.05 | -83.07 |
Pretax Income | -3,505 | -11,427 | -87,803 | -27,348 | -19,604 | 12,058 |
Income Tax Expense | 439.57 | -90.48 | -583.85 | -170.87 | - | - |
Earnings From Continuing Operations | -3,945 | -11,337 | -87,219 | -27,177 | -19,604 | 12,058 |
Net Income to Company | -3,945 | -11,337 | -87,219 | -27,177 | -19,604 | 12,058 |
Net Income | -3,945 | -11,337 | -87,219 | -27,177 | -19,604 | 12,058 |
Net Income to Common | -3,945 | -11,337 | -87,219 | -27,177 | -19,604 | 12,058 |
Net Income Growth | - | - | - | - | - | 637.48% |
Shares Outstanding (Basic) | 42 | 41 | 40 | 39 | 39 | 40 |
Shares Outstanding (Diluted) | 42 | 41 | 40 | 39 | 39 | 43 |
Shares Change (YoY) | 5.56% | 4.09% | 0.66% | -0.17% | -8.46% | 9.88% |
EPS (Basic) | -94.10 | -274.98 | -2202.00 | -690.62 | -497.32 | 303.98 |
EPS (Diluted) | -94.10 | -274.98 | -2202.00 | -691.00 | -497.32 | 280.00 |
EPS Growth | - | - | - | - | - | 571.14% |
Free Cash Flow | -1,814 | 111.3 | -31,858 | -4,895 | -12,045 | -10,341 |
Free Cash Flow Per Share | -43.27 | 2.70 | -804.31 | -124.40 | -305.57 | -240.13 |
Gross Margin | 40.92% | 42.70% | 31.08% | 35.92% | 28.66% | 30.92% |
Operating Margin | 6.85% | 4.65% | -61.15% | -10.90% | -5.18% | -4.06% |
Profit Margin | -4.51% | -13.91% | -139.12% | -37.64% | -25.86% | 19.97% |
Free Cash Flow Margin | -2.08% | 0.14% | -50.82% | -6.78% | -15.89% | -17.13% |
EBITDA | 10,217 | 8,101 | -33,999 | -3,877 | -890.45 | -135.45 |
EBITDA Margin | 11.69% | 9.94% | -54.23% | -5.37% | -1.18% | -0.22% |
D&A For EBITDA | 4,233 | 4,309 | 4,338 | 3,991 | 3,039 | 2,315 |
EBIT | 5,984 | 3,793 | -38,337 | -7,868 | -3,929 | -2,450 |
EBIT Margin | 6.85% | 4.65% | -61.15% | -10.90% | -5.18% | -4.06% |
Advertising Expenses | - | 107.5 | 200.68 | 159.38 | 2.3 | 116.38 |